Medicine and device developers continue to focus on patient safety long after receiving market approval. This post-marketing phase is a critical stage for pharmacovigilance, offering insight into ...

The recent collapse of the Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG) negotiations has added more uncertainty and complexity to a UK healthcare system already undergoing ...

Of all the healthcare policies the government blasted out over the summer, one should have stood out for pharma. The NHS is edging towards one of the most radical reforms in its history: the creation ...

Despite bold ambitions in the Life Sciences Vision and NHS 10-Year Plan, uptake of new medicines remains slow. Can industry, government and providers finally bridge the gap between approval and access ...

AI is already playing a fundamental role in every stage of the drug discovery process – from ideation all the way through to drugs reaching patients. This integration is accelerating innovation and ...

Dr John Snowden, Consultant Haematologist and Director of Blood and Marrow Transplant at Sheffield Teaching Hospitals, said: “This is a landmark trial which could change the way we treat systemic ...

Although many of the terms in a ‘nurse’ word cloud may hint at the broad job description (care, diligence, compassion etc), I view nursing instead as the glorious lightning bolt between founding ...

AC Immune SA has announced peer-reviewed results from its phase 1b/2a trial of two Tau-targeting active immunotherapies for early Alzheimer’s disease. The study compared ACI-35.030, developed with AC ...

As an occupation at the very epicentre of healthcare, the nurse is a constant and iconic presence. In this edition of PharmaTimes, we demonstrate how this reassuring and essential presence within our ...

Xeltis has announced successful results from its aXess EU phase 3 trial, confirming the potential of its restorative vascular access conduit for patients undergoing hemodialysis. The multicentre study ...

Acella Pharmaceuticals and Neuvosyn Laboratories have announced positive topline results from a phase 2 clinical trial of North Star, an investigational desiccated thyroid extract (DTE) for ...